Acs Tqip Palliative Care Best Practices Guidelines
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Changing Nature of Palliative Care: Implications for Allied Health Professionals’ Educational and Training Needs
healthcare Article The Changing Nature of Palliative Care: Implications for Allied Health Professionals’ Educational and Training Needs Deidre D. Morgan 1,* , Deb Rawlings 1,2 , Carly J. Moores 3, Lizzie Button 2 and Jennifer J. Tieman 1,2 1 Palliative and Supportive Services, College of Nursing and Health Sciences, Flinders University, Adelaide 5001, Australia; deborah.rawlings@flinders.edu.au (D.R.); jennifer.tieman@flinders.edu.au (J.J.T.) 2 CareSearch, Flinders University, Adelaide 5001, Australia; elizabeth.button@flinders.edu.au 3 Nutrition and Dietetics, College of Nursing and Health Sciences, Flinders University, Adelaide 5001, Australia; carly.moores@flinders.edu.au * Correspondence: deidre.morgan@flinders.edu.au; Tel: +61-8-7221-8220 Received: 11 August 2019; Accepted: 26 September 2019; Published: 28 September 2019 Abstract: CareSearch is an Australian Government Department of Health funded repository of evidence-based palliative care information and resources. The CareSearch Allied Health Hub was developed in 2013 to support all allied health professionals working with palliative care clients in all clinical settings. This cross-sectional online survey sought to elicit allied health professionals palliative care experiences and subsequent considerations for educational and clinical practice needs. The survey was disseminated nationally via a range of organisations. Data was collected about palliative care knowledge, experience working with palliative care clients and professional development needs. Data were evaluated by profession, experience and practice setting. In total, 217 respondents answered one or more survey questions (94%). Respondents (65%) reported seeing >15 palliative care clients per month with 84% seen in hospital and community settings. Undergraduate education underprepared or partially prepared allied health professionals to work with these clients (96%) and 67% identified the need for further education. -
Focus on Geriatric Trauma
European Journal of Trauma and Emergency Surgery (2019) 45:179–180 https://doi.org/10.1007/s00068-019-01107-3 EDITORIAL Focus on geriatric trauma Pol Maria Rommens1 Received: 15 February 2019 / Accepted: 26 February 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Life expectancy is high and still growing in our societies. be minimal invasive; the implants use long bony corridors With higher age, the incidence of age-related diseases is for bridging or splinting. Conservative treatment is a valid increasing. Osteoporosis is a typical disease of the elderly, alternative in elderly patients with solitary lesions and low which is characterized by a decrease of bone mineral density. functional demands. Therefore, there is a higher risk of fractures due to low- Schmidt et al. [2] performed a logistic regression analysis energy trauma. The aged patient with a fracture is not com- on 1589 adult patients with isolated mild traumatic brain parable with an adolescent or adult with a musculoskeletal injury to assess the odds of any in-hospital adverse event by injury. Aged patients have a restricted physiological reserve age group, adjusted for gender and comorbidities. An expo- and do not afford long and invasive surgeries. In addition, nential increase of adverse events was observed after the age the strength of the fractured bone is lower. Consequently, of 75 years. Most important complications were urinary tract the prerequisites for fracture care are different. Conservative infection, delirium, respiratory complications and early com- management plays a more important role. However, surgical plications in trauma. These results demonstrate that geriat- treatment is obligatory in patients with unstable fractures ric trauma patients, who need surgical interventions, are at of the spine, pelvis, hip and lower extremities. -
New Zealand Palliative Care Glossary
New Zealand Palliative Care Glossary Released 2015 health.govt.nz Citation: Ministry of Health. 2015. New Zealand Palliative Care Glossary. Wellington: Ministry of Health. Published in December 2015 by the Ministry of Health PO Box 5013, Wellington 6145, New Zealand ISBN 978-0-947491-36-9 (online) HP 6308 This document is available at health.govt.nz This work is licensed under the Creative Commons Attribution 4.0 International licence. In essence, you are free to: share ie, copy and redistribute the material in any medium or format; adapt ie, remix, transform and build upon the material. You must give appropriate credit, provide a link to the licence and indicate if changes were made. Palliative Care Council of New Zealand The Palliative Care Council was established in 2008 by Cancer Control New Zealand to provide independent and expert advice to the Minister of Health and to report on New Zealand’s performance in providing palliative and end of life care. Cancer Control New Zealand and the Palliative Care Council was disestablished on 8 August 2015 by the Minister of Health. The Palliative Care Council included representatives from the New Zealand Branch of the Australian and New Zealand Society of Palliative Medicine, Hospice New Zealand, Hospital Palliative Care New Zealand and Palliative Care Nurses New Zealand, and members nominated by the Royal NZ College of GPs/NZ Rural GP network, Nursing Council of NZ, Māori and consumers. The New Zealand Palliative Care Glossary is now the responsibility of the Ministry of Health. PO Box 5013 -
No Autopsies on COVID-19 Deaths: a Missed Opportunity and the Lockdown of Science
Journal of Clinical Medicine Review No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science 1, 2, 3 1 1 Monica Salerno y, Francesco Sessa y , Amalia Piscopo , Angelo Montana , Marco Torrisi , Federico Patanè 1, Paolo Murabito 4, Giovanni Li Volti 5,* and Cristoforo Pomara 1,* 1 Department of Medical, Surgical and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95121 Catania, Italy; [email protected] (M.S.); [email protected] (A.M.); [email protected] (M.T.); [email protected] (F.P.) 2 Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; [email protected] 3 Department of Law, Forensic Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy; [email protected] 4 Department of General surgery and medical-surgical specialties, University of Catania, 95121 Catania, Italy; [email protected] 5 Department of Biomedical and Biotechnological Sciences, University of Catania, 95121 Catania, Italy * Correspondence: [email protected] (G.L.V.); [email protected] (C.P.); Tel.: +39-095-478-1357 or +39-339-304-6369 (G.L.V.); +39-095-378-2153 or +39-333-246-6148 (C.P.) These authors contributed equally to this work. y Received: 12 March 2020; Accepted: 13 May 2020; Published: 14 May 2020 Abstract: Background: The current outbreak of COVID-19 infection, which started in Wuhan, Hubei province, China, in December 2019, is an ongoing challenge and a significant threat to public health requiring surveillance, prompt diagnosis, and research efforts to understand a new, emergent, and unknown pathogen and to develop effective therapies. -
Massachusetts Board of Registration in Pharmacy Published to Promote Compliance of Pharmacy and Drug Law
August 2020 News Massachusetts Board of Registration in Pharmacy Published to promote compliance of pharmacy and drug law 239 Causeway Street, 5th Floor • Boston, MA 02114 • www.mass.gov/dph/boards/pharmacy Acute Use Medications for Inpatient also known as automated dispensing machines and automated Hospice Facilities dispensing cabinets. In March 2020, a circular letter was jointly issued from the The use of an ADD in a Massachusetts-licensed health care Massachusetts Board of Registration in Pharmacy and the facility is permitted only if the facility’s licensure allows it to Bureau of Health Care Safety and Quality outlining a process store and dispense medications. For instance, if there is not through which an inpatient hospice facility’s pharmacy pro- an on-site pharmacy, prior approval for use and placement vider may store certain non-patient-specific medications at of the ADD must be obtained from the agency that licenses the facility. With this change, hospice inpatient facilities (as that facility. defined in105 Code of Massachusetts Regulations 141.000) Medications must be provided in unit-of-use packaging for will now have the ability to treat patient symptoms that are a single dose or a specific person and remain the property of not life-threatening, but require medication management the pharmacy until dispensed pursuant to a patient-specific in a timely manner to provide prompt palliative care. A list prescription or order. Any losses must be reported to the of medications that may be stored, as well as details on the pharmacy’s licensing body (ie, Board of Pharmacy or Drug requirement to store them in an automated dispensing device Control Program). -
Palliative Care Glossary
(http://getpalliativecare.org) Glossary A adjuvant therapy A treatment used with a medication to aid its effect. advance directive Written or verbal instructions for your care if you are unable to make decisions. C cardiopulmonary resuscitation (CPR) A procedure used when a patient′s heart stops beating; it can involve compressions of the chest or electrical stimulation. consulting physician A doctor with special training or experience who is called in to assist the primary attending physician in matters that need more specialized care. coordination of care An approach in which all members of the medical team work together to plan for a patient′s care in the hospital and for discharge. D do not resuscitate (DNR) order A physician's order not to attempt CPR if a patient′s heart or breathing stops. The order is written at the request of the patient or family, but it must be signed by a physician to be valid. There are separate versions for home and hospital. durable power of attorney for healthcare A document that designates the person you trust to make medical decisions on your behalf if you are unable. H healthcare proxy Similar to a durable power of attorney for healthcare: a document that designates the person you trust to make medical decisions on your behalf if you are unable. home care Services provided in the home, such as nursing and physical therapy. hospice Considered a model of quality care, hospice focuses on relieving symptoms and supporting patients with a life expectancy of months, not years. Hospice involves a team-oriented approach to expert medical care, pain management and emotional and spiritual support. -
Pharmacist's Role in Palliative and Hospice Care
456 Medication Therapy and Patient Care: Specific Practice Areas–Guidelines ASHP Guidelines on the Pharmacist’s Role in Palliative and Hospice Care Palliative care arose from the modern hospice movement and and in advanced clinical practice (medication therapy man- has evolved significantly over the past 50 years.1 Numerous agement services, pain and symptom management consulta- definitions exist to describe palliative care, all of which fo- tions, and interdisciplinary team participation). cus on aggressively addressing suffering. The World Health Organization and the U.S. Department of Health and Human Purpose Services both stipulate the tenets of palliative care to include a patient-centered and family-centered approach to care, In 2002, ASHP published the ASHP Statement on the with the goal of maximizing quality of life while minimiz- Pharmacist’s Role in Hospice and Palliative Care.28 These 2 ing suffering. In its clinical practice guidelines, the National guidelines extend beyond the scope of that statement and Consensus Project for Quality Palliative Care of the National are intended to define the role of the pharmacist engaged in Quality Forum (NQF) describes palliative care as “patient the practice of PHC. Role definition will include goals for and family-centered care that optimizes quality of life by an- providing services that establish general principles and best ticipating, preventing, and treating suffering . throughout practices in the care of this patient population. This docu- the continuum of illness . addressing the -
The TLC Model of Palliative Care in the Elderly: Preliminary Application in the Assisted Living Setting
The TLC Model of Palliative Care in the Elderly: Preliminary Application in the Assisted Living Setting 1 Anthony F. Jerant, MD ABSTRACT 2 Rahman S. Azari, PhD Substantial shortfalls in the quality of palliative care of the elderly can be attrib- Thomas S. Nesbitt, MD, MPH1 uted to 5 fundamental fl aws in the way end-of-life care is currently delivered. First, palliative care is viewed as a terminal event rather than a longitudinal 3 Frederick J. Meyers, MD process, resulting in a reactive approach and unnecessary preterminal distress in 1Department of Family and Community elderly patients suffering from chronic, slowly progressive illnesses. Second, pal- Medicine, University of California Davis liative care is defi ned in terms of a false dichotomy between symptomatic and dis- School of Medicine, Sacramento, Calif ease-focused treatment, which distracts attention from the proper focus of healing 2Department of Statistics, University of illness. Third, the decision about whether the focus of care should be palliative is California Davis School of Medicine, not negotiated among patients, family members, and providers. Fourth, patient Sacramento, Calif autonomy in making treatment choices is accorded undue prominence relative to more salient patient choices, such as coming to terms with their place in the 3Department of Internal Medicine, Univer- trajectory of chronic illness. Fifth, palliative care is a parallel system rather than an sity of California Davis School of Medicine, Sacramento, Calif integrated primary care process. A new theoretical framework—the TLC model— addresses these fl aws in the provision of palliative care for elderly persons. In this model, optimal palliative care is envisioned as timely and team oriented, longi- tudinal, collaborative and comprehensive. -
The Decline in Child Mortality: a Reappraisal Omar B
Theme Papers The decline in child mortality: a reappraisal Omar B. Ahmad,1 Alan D. Lopez,2 & Mie Inoue3 The present paper examines, describes and documents country-specific trends in under-five mortality rates (i.e., mortality among children under five years of age) in the 1990s. Our analysis updates previous studies by UNICEF, the World Bank and the United Nations. It identifies countries and WHO regions where sustained improvement has occurred and those where setbacks are evident. A consistent series of estimates of under-five mortality rate is provided and an indication is given of historical trends during the period 1950–2000 for both developed and developing countries. It is estimated that 10.5 million children aged 0–4 years died in 1999, about 2.2 million or 17.5% fewer than a decade earlier. On average about 15% of newborn children in Africa are expected to die before reaching their fifth birthday. The corresponding figures for many other parts of the developing world are in the range 3–8% and that for Europe is under 2%. During the 1990s the decline in child mortality decelerated in all the WHO regions except the Western Pacific but there is no widespread evidence of rising child mortality rates. At the country level there are exceptions in southern Africa where the prevalence of HIV is extremely high and in Asia where a few countries are beset by economic difficulties. The slowdown in the rate of decline is of particular concern in Africa and South-East Asia because it is occurring at relatively high levels of mortality, and in countries experiencing severe economic dislocation. -
Cross-Country Evidence on the Association Between Contact Tracing
www.nature.com/scientificreports OPEN Cross‑country evidence on the association between contact tracing and COVID‑19 case fatality rates Abdullah Yalaman1*, Gokce Basbug2, Ceyhun Elgin3 & Alison P. Galvani4 The coronavirus disease (COVID‑19) outbreak has killed over a million people since its emergence in late 2019. However, there has been substantial variability in the policies and intensity of diagnostic eforts between countries. In this paper, we quantitatively evaluate the association between national contact tracing policies and case fatality rates of COVID‑19 in 138 countries. Our regression analyses indicate that countries that implement comprehensive contact tracing have signifcantly lower case fatality rates. This association of contact tracing policy and case fatality rates is robust in our longitudinal regression models, even after controlling for the number of tests conducted and non‑ pharmaceutical control measures adopted by governments. Our results suggest that comprehensive contact tracing is instrumental not only to curtailing transmission but also to reducing case fatality rates. Contact tracing achieves the early detection and isolation of secondary cases which are particularly important given that the peak in infectiousness occurs during the presymptomatic phase. The early detection achieved by contact tracing accelerates the rate at which infected individuals receive medical care they need to maximize their chance of recovery. In addition, the combination of reduced transmission and more rapid recovery diminishes the burden on the healthcare system which in turn ensures that the resources remain available for individuals who do become infected. Te ongoing coronavirus disease (COVID-19) outbreak has spread to 213 countries and territories, causing more than 47,000,000 cases and over 1.2 million deaths as of November 2020. -
MAIN CAUSES of MORTALITY Over 5 200 000 People Died in EU Countries in 2015 Diseases, Followed by Pneumonia (See Indicator (Figure 3.7)
II.3. HEALTH STATUS MAIN CAUSES OF MORTALITY Over 5 200 000 people died in EU countries in 2015 diseases, followed by pneumonia (see indicator (Figure 3.7). An unusual large increase in the number of “Mortality from respiratory diseases”). deaths in 2015 explains the reduction in life External causes of death, which include accidents, expectancy in many countries compared with 2014 (see suicides, homicides and other violent causes of death, indicator “Trends in life expectancy”). The higher were responsible for 3% of all deaths among women and number of deaths in 2015 across EU countries was 6% of deaths among men in EU countries in 2015. The concentrated mainly among people aged 75 and over, most important causes of violent deaths are road traffic and was attributed mainly to higher mortality from accidents and other accidental deaths, and suicides. influenza and pneumonia triggering cardiorespiratory Road traffic accidents are a particularly important cause events, Alzheimer’s disease and other dementias, and of death among young people (aged 18-25), whereas heart diseases. suicide rates generally increase with age. Slightly more women than men died across EU More than 80% of all deaths in EU countries occur countries in 2015, as there are more women in the after the age of 65. While the main cause of death population, particularly in older age groups. Once the among people aged over 65 is circulatory diseases, the population structure is adjusted by age, the age- main cause for people under 65 is cancer, particularly standardised mortality rate was about 50% higher among women (Eurostat, 2018). -
Global Atlas of Palliative Care at the End of Life
Global Atlas of Palliative Care at the End of Life January 2014 Acknowledgements and authorship Edited by: Stephen R. Connor, PhD, Senior Fellow to the Worldwide Palliative Care Alliance (WPCA). Maria Cecilia Sepulveda Bermedo, MD, Senior Adviser Cancer Control, Chronic Diseases Prevention and Management, Chronic Diseases and Health Promotion, World Health Organization. The views expressed in this publication do not necessarily represent the decisions, policy or views of the World Health Organization. This publication was supported in part by a grant from the Open Society Foundations’ International Palliative Care Initiative. Special thanks to Mary Callaway and Dr Kathleen Foley. Contributing writers: Sharon Baxter, MSW, Canadian Hospice Palliative Care Association, Canada Samira K. Beckwith, ACSW, LCSW, FACHE, Hope Hospice, Ft Myers, FL, USA David Clark, PhD – University of Glasgow, Scotland James Cleary, MD – Pain and Policies Study Group, Madison, WI, USA Dennis Falzon, MD – WHO Global TB Program, WHO Geneva Philippe Glaziou, MD, MPhil, Dip Stat – WHO Global TB Program, WHO Geneva Peter Holliday, St. Giles Hospice, Litchfield, England Ernesto Jaramillo, MD – WHO Global TB Program, WHO Geneva Eric L. Krakauer, MD, PhD – Harvard Medical School Center for Palliative Care, Boston, MA, USA Suresh Kumar, MD – Neighborhood Network in Palliative Care, Kerala, India Diederik Lohman – Human Rights Watch, New York, USA Thomas Lynch, PhD – International Observatory for End of Life Care, Lancaster, England Paul Z. Mmbando (MBChB, MPH, DrH) Evangelical Lutheran Church, Arusha, Tanzania Claire Morris, Worldwide Palliative Care Alliance, London, England Daniela Mosoiu, MD – Hospice Casa Sperantei, Brasov, Romania Fliss Murtagh FRCP PhD MRCGP, Cicely Saunders Institute, Kings College London Roberto Wenk, MD – Programa Argentino de Medicina Paliativa Fundación, Argentina In addition, the editors would like to thank the following: All WHO collaborating centres on palliative care (see appendix for details) Ricardo X.